Life Sciences Times, Author at Life Sciences Times

Beneath the biotech boom

April 17, 2025

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

April 17, 2025

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

April 13, 2025

THIS WEEK'S STORIES

Sollis Health Names Katy Marshall Chief Growth Officer

April 14, 2025

Glycomine Secures $115 Million in Series C Funding to Advance PMM2-CDG Drug Candidate

April 16, 2025

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

April 18, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Life Sciences Times

TOP AUTHORS

Most Read

Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine

Beneath the biotech boom

EDITOR PICKS

Beneath the biotech boom

Podimetrics and HealthMed Partner to Expand Diabetes Complication Prevention for Employers and Healthcare Systems

Novartis to Invest $23 Billion in Expanding U.S. Manufacturing and Research Footprint

THIS WEEK'S STORIES

Sollis Health Names Katy Marshall Chief Growth Officer

Glycomine Secures $115 Million in Series C Funding to Advance PMM2-CDG Drug Candidate

$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals

POPULAR CATEGORY

ABOUT US

FOLLOW US